
Dimitris Mastellos
@dmastellos
Father of two, husband, biologist, researcher @NCSR_Demokritos intrigued by innate immunity, complement biology & therapeutics; retired classical guitar player
ID: 1009483546988367873
https://dmastellos.wixsite.com/mol-immunlab 20-06-2018 17:10:07
2,2K Tweet
582 Followers
387 Following




Zymogen activation is a ubiquitous strategy for regulating enzyme activity. In our Journal of Biological Chemistry paper led by Duan, we show that blocking this fundamental process is used to inhibit the first proteolytic event of the classical #complement pathway 👇 doi.org/10.1016/j.jbc.…


The infinite beauty of finely regulated biology from a neutrophil's perspective...with the helping hand of #complementbiology! The recent study by Hsu et al. sciencedirect.com/science/articl… nicely placed in context by Lai Guan NG and Immanuel Kwok in this preview sciencedirect.com/science/articl…



Our News & Views article with Dimitris Mastellos discussing two recent Nature studies that report #granzymeK-mediated #complement activation in pathological contexts of CD8+ #Tcell-driven tissue #inflammation is now out in Nature Immunology nature.com/articles/s4159…


Program Updated: 17th Int'l Conference on #Complement #Therapeutics held at the #KalimeraKriti Conference Center from May 10-15 in #Sissi #Crete #Greece aegeanconferences.org/src/App/sessio… Dimitris Mastellos Lubka Roumenina John D. Lambris, Ph.D.



Pleased to share our newly published paper entitled: "Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8–Driven Inflammation in COVID-19" onlinelibrary.wiley.com/doi/10.1111/im… This work, which was done a few years back, investigated the effects of AMY-101 in treating severe





